Progyny, Inc. - Common Stock (NQ:PGNY)

27.69 -0.44 (-1.56%)

Delayed Quote Updated: 2:27 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Progyny, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Detroit Pistons Become First Professional Sports Team in the United States to Partner with Progyny to Provide Comprehensive, Value-Based Family Building Care

March 01, 2023

From Progyny

Via GlobeNewswire

Why Titan International Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 28, 2023

Gainers Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) shares jumped 153% to $3.24 after the company announced the launch of PrecisionCHD, an integrated epigenetic-genetic blood test for the early...

Via Benzinga

Why Progyny Shares Are Trading Higher Today ↗

February 28, 2023

Progyny (NASDAQ: PGNY) shares are trading higher on Tuesday after the company reported better-than-expected Q4 results.

Via Benzinga

Earnings Preview: Progyny ↗

February 24, 2023

Via Benzinga

Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday ↗

February 28, 2023

U.S. stocks traded lower, with the Dow Jones dropping more than 150 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Why Catalyst Biosciences Shares Are Trading Higher By 105%; Here Are 20 Stocks Moving Premarket ↗

February 28, 2023

Gainers Catalyst Biosciences Inc (NASDAQ: CBIO) rose 105% to $0.49 in pre-market trading. South Korea's GC Biopharma said it has signed an asset purchase agreement with Catalyst Biosciences to acquire...

Via Benzinga

Zoom Is Zooming, But This Health-Tech Stock Is Doing Even Better ↗

February 27, 2023

Big after-hours gains followed a strong day on Wall Street.

Via The Motley Fool

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 27, 2023

Via Benzinga

Progyny, Inc. Announces Fourth Quarter 2022 Results

February 27, 2023

From Progyny

Via GlobeNewswire

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Progyny, Inc.Investors to Inquire About Securities Class Action Investigation - PGNY

February 26, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY

February 19, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Earnings Scheduled For February 27, 2023 ↗

February 27, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.

Via Benzinga

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2022 Results Report

February 13, 2023

From Progyny

Via GlobeNewswire

PROGYNY ALERT: Bragar Eagel & Squire, P.C. is Investigating Progyny, Inc. on Behalf of Progyny Stockholders and Encourages Investors to Contact the Firm

February 08, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

What Does Amazon's Acquisition of 1LifeMedical Mean To Investors?

January 10, 2023

After the announcement in July, the Amazon acquisition of One Medical is complete. What does this deal mean for healthcare or tech investors?

Via MarketBeat

Topics Initial Public Offering Regulatory Compliance

7 Stocks With a Forward P/E of 25 to Run Away From ↗

January 09, 2023

Expensive stocks with all the warning signs of having a high a risk of missing expectations are some of the stocks to avoid.

Via InvestorPlace

Progyny to Discuss its Strong 2022 Financial Performance at Upcoming Investor Conference

January 09, 2023

From Progyny

Via GlobeNewswire

PROGYNY ALERT: Bragar Eagel & Squire, P.C. is Investigating Progyny, Inc. on Behalf of Progyny Stockholders and Encourages Investors to Contact the Firm

December 28, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation - PGNY

December 27, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

4 Unstoppable Multibaggers to Buy in 2023 and Hold for the Next Decade ↗

December 27, 2022

Three-year revenue growth rates between 39% and 54% are projected, making these stocks prime multibagger candidates.

Via The Motley Fool

PROGYNY ALERT: Bragar Eagel & Squire, P.C. is Investigating Progyny, Inc. on Behalf of Progyny Stockholders and Encourages Investors to Contact the Firm

December 23, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

PROGYNY ALERT: Bragar Eagel & Squire, P.C. is Investigating Progyny, Inc. on Behalf of Progyny Stockholders and Encourages Investors to Contact the Firm

December 19, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday ↗

December 19, 2022

Morgan Stanley cut VTEX (NYSE: VTEX) price target from $7 to $5. Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on...

Via Benzinga

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Progyny, Inc. and Encourages Investors with Losses to Contact the Firm

December 15, 2022

From The Schall Law Firm

Via Business Wire

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Progyny, Inc. and Encourages Investors with Losses to Contact the Firm

December 10, 2022

From The Schall Law Firm

Via Business Wire

PGNY INVESTOR NOTICE: Rosen Law Firm Encourages Progyny, Inc. Investors to Inquire About Securities Class Action Investigation – PGNY

December 08, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

Progyny Raises 2022 Financial Guidance

November 28, 2022

Shipments of Key Fertility Medication Have Resumed

From Progyny

Via GlobeNewswire

Progyny, Inc. Announces Third Quarter 2022 Results

November 03, 2022

From Progyny

Via GlobeNewswire

A Preview Of Progyny's Earnings ↗

November 02, 2022

Progyny (NASDAQ:PGNY) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Progyny will report...

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.